Invitae

Invitae Inventory Turnover

Delisted

The Inventory Turnover Ratio of Invitae (NVTAQ) as of Oct 5, 2026 is 13.72. In the previous year, Inventory Turnover Ratio was 10.47 — a change of 31.09% (higher).

Inventory Turnover

13.72

YoY

31.09%

Last updated:

Inventory Turnover Ratio of Invitae is 2026 13.72 . Inventory Turnover Ratio of Invitae was 2025 10.47 . It decreases by 31.09% higher compared to the previous year.

The Invitae Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2017
9.29 USD
Jan 1, 2018
9.65 USD
Jan 1, 2019
17.89 USD
Jan 1, 2020
6.34 USD
Jan 1, 2021
10.47 USD
Jan 1, 2022
13.72 USD
The Invitae Inventory Turnover history
YEARInventory TurnoverYoY
13.72+31.09%
10.47+65.20%
6.34-64.59%
17.89+85.41%
9.65+3.94%
9.29—
Access this data via the Eulerpool API

Invitae Stock analysis

What does Invitae do? Invitae Corp is a US-based company specialized in providing genetic tests for the diagnosis, treatment, and prevention of diseases. It was founded in 2010 and is headquartered in San Francisco, California. The company's goal is to lower the cost of genetic testing and increase accessibility for patients through automation and sample pooling methods. Invitae has received significant funding and has expanded its capital through multiple rounds of investments from venture capital firms, totaling nearly half a billion dollars. Its business model focuses on offering genetic tests to a wide range of patient groups, streamlining the testing processes through automation and software optimization. Invitae serves consumers directly, as well as medical professionals, hospitals, health centers, laboratories, and health insurance companies. The company aims to improve disease diagnosis and early detection while promoting long-term patient health. Invitae has broadened its capabilities through strategic acquisitions and partnerships, consolidating genetic data on a single platform. It offers a diverse portfolio of genetic tests for the diagnosis, treatment, and prevention of various diseases, including cancer predisposition, cardiovascular diseases, rare inherited diseases, neurological disorders, and medical genomics. The company also provides genetic counseling and family-oriented diagnosis services, along with an online platform facilitating interactive communication between doctors and patients, enabling the sharing and presentation of genetic information and test results. Invitae is an innovative company that has established itself as a market leader in genetic testing, offering a wide range of products and services facilitated by advanced technologies and data storage solutions. The recent acquisitions and partnerships have expanded Invitae's portfolio, improved its technology platform, and strengthened its position as a provider of high-quality healthcare services, enabling well-informed decision-making for patients and medical professionals. Invitae is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Invitae stock

Inventory Turnover Ratio of Invitae is 13.72 in 2026.

Inventory Turnover Ratio of Invitae changed from 10.47 to 13.72, representing a 31.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio Invitae since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's Invitae with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

Profitability — Invitae

All Key Metrics — Invitae